Related Experiment Video
Updated: Nov 26, 2025
09:01
Vascular Occlusion Training for Inclusion Body Myositis: A Novel Therapeutic Approach
Published on: June 5, 2010
14.4K
[Arteriofit: a supervised exercise training program, recommended as a first-line treatment in intermittent
Stéphanie Zbinden1, Frédéric Sittarame2, Marc Righini1
1Service d'angiologie et d'hémostase, Département de médecine, HUG, 1211 Genève 14.
Revue Medicale Suisse
|December 10, 2020
Summary
Supervised exercise training significantly improves walking ability and quality of life for individuals with lower extremities arterial disease (LEAD). This approach, combined with revascularization, offers enhanced benefits for managing LEAD, a common manifestation of atherosclerosis.
Area of Science:
- Vascular Medicine
- Cardiovascular Disease
- Atherosclerosis Research
Background:
- Lower extremities arterial disease (LEAD) is the third most prevalent form of atherosclerosis, carrying a cardiovascular event risk comparable to coronary artery disease.
- Current management strategies emphasize risk factor control, pharmacotherapy, and supervised exercise training (SET).
Purpose of the Study:
- To highlight the efficacy of supervised exercise training (SET) as a cornerstone in managing lower extremities arterial disease (LEAD).
- To underscore the synergistic benefits of SET when combined with revascularization procedures.
- To raise awareness of established federal exercise programs in Switzerland for LEAD patients.
Main Methods:
- Review of current management protocols for lower extremities arterial disease (LEAD).
- Comparative analysis of exercise modalities for LEAD, focusing on supervised exercise training (SET).
- Evaluation of outcomes associated with SET, including walking parameters and quality of life metrics.
- Assessment of combined SET and revascularization outcomes.
- Overview of existing federal exercise programs in Switzerland.
Main Results:
- Supervised exercise training (SET) demonstrates superiority over other exercise forms in improving key metrics for LEAD patients.
- Significant improvements observed in walking time, maximum walking distance, and pain-free walking distance.
- Enhanced quality of life scores reported by patients undergoing SET.
- Combined therapy of SET and revascularization yields augmented clinical benefits.
- Federal programs supporting SET for LEAD exist in multiple Swiss cities but lack widespread recognition.
Conclusions:
- Supervised exercise training (SET) is a highly effective, evidence-based intervention for improving functional capacity and quality of life in patients with lower extremities arterial disease (LEAD).
- The combination of SET with revascularization offers superior outcomes.
- Increased awareness and utilization of established supervised exercise programs are crucial for optimizing LEAD management in Switzerland.
Related Concept Videos
01:27Peripheral Artery Disease III: Interprofessional Care
125
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
125
01:26Atherosclerosis III: Management
156
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
156
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
330
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
330
01:30Peripheral Artery Disease I: Introduction
161
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
161
01:20Exercise and Cardiovascular Response
3.6K
Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
3.6K
01:21Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
175
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
175